Home/Filings/4/0000905148-24-003242
4//SEC Filing

Hyllengren Eric J 4

Accession 0000905148-24-003242

CIK 0001604464other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 6:04 PM ET

Size

5.0 KB

Accession

0000905148-24-003242

Insider Transaction Report

Form 4
Period: 2024-11-18
Hyllengren Eric J
EVP, CFO and COO
Transactions
  • Sale

    Common Stock

    2024-11-18$11.20/sh1,364$15,27423,392 total
Footnotes (2)
  • [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
  • [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 18, 2024 and November 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

Documents

1 file

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0001966926

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 6:04 PM ET
Size
5.0 KB